SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-24-025402
Filing Date
2024-03-05
Accepted
2024-03-05 07:35:27
Documents
84
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K dyn-20231231.htm   iXBRL 10-K 2652159
2 EX-21.1 dyn-ex21_1.htm EX-21.1 4962
3 EX-23.1 dyn-ex23_1.htm EX-23.1 4100
4 EX-31.1 dyn-ex31_1.htm EX-31.1 11508
5 EX-31.2 dyn-ex31_2.htm EX-31.2 11226
6 EX-32.1 dyn-ex32_1.htm EX-32.1 5753
7 EX-32.2 dyn-ex32_2.htm EX-32.2 5569
8 EX-97 dyn-ex97.htm EX-97 25900
9 GRAPHIC img108075666_0.jpg GRAPHIC 189282
10 GRAPHIC img108075666_1.jpg GRAPHIC 15301
11 GRAPHIC img108075666_2.jpg GRAPHIC 61075
12 GRAPHIC img108075666_3.jpg GRAPHIC 332962
13 GRAPHIC img108075666_4.jpg GRAPHIC 319508
14 GRAPHIC img108075666_5.jpg GRAPHIC 269848
15 GRAPHIC img108075666_6.jpg GRAPHIC 246579
  Complete submission text file 0000950170-24-025402.txt   12423222

Data Files

Seq Description Document Type Size
16 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT dyn-20231231.xsd EX-101.SCH 1216104
86 EXTRACTED XBRL INSTANCE DOCUMENT dyn-20231231_htm.xml XML 1314089
Mailing Address 1560 TRAPELO ROAD WALTHAM MA 02451
Business Address 1560 TRAPELO ROAD WALTHAM MA 02451 (781) 786-8230
Dyne Therapeutics, Inc. (Filer) CIK: 0001818794 (see all company filings)

IRS No.: 364883909 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39509 | Film No.: 24718294
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)